This review focuses on the emerging evidence for the multiple roles of CCL4-related mechanisms, including those of CCL4 and one of its major receptors, fifth CC chemokine receptor (CCR5), in both experimental and clinical DM and atherosclerosis cardiovascular diseases. This evidence concerns the gene CCL4 and cardiovascular disorder.